Business of the House

David Johnston Excerpts

Thursday 27th May 2021 Commons Chamber

[Madam Deputy Speaker (Dame Rosie Winterton)]

Order. I need to finish this session by about 25 past at the latest, because we have two very well-subscribed debates to follow. If I am to get everybody in, I must ask the remaining speakers to ask short questions, and I am sure that the Leader of the House will respond with shorter answers.

[David Johnston (Wantage) (Con)]

Last week was, of course, Dementia Action Week, and when I met with the Alzheimer’s Society, it presented several worrying statistics, one of which showed the rise in the use of anti-psychotic drugs. Based on the stats in Oxfordshire, fewer than one in five of the people who had been prescribed anti-psychotic drugs actually had a diagnosis of psychosis. Will the Leader of the House please get a statement from the Department for Health and Social Care about what lies behind that rise in the use of anti-psychotic drugs in people who do not actually have psychosis?

[Mr Rees-Mogg]

I am grateful to my hon. Friend for raising that deeply concerning issue. NHS England and NHS Improvement continue to monitor the monthly data published by NHS Digital on the prescribing of anti-psychotic medication for people diagnosed with dementia. However, the issue he raises needs a fuller answer, and I will take it up with the Department on his behalf.